Breaking News

ABL Awarded NIH Biologics Development Contract

Will provide cGMP manufacturing and GLP preclinical services to support translational development of therapeutics for NIH's development programs.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Advanced BioScience Laboratories (ABL), a global CDMO and CRO to the U.S. Government and biopharmaceutical industry, is one of three contractors awarded an Indefinite Delivery, Indefinite Quantity (IDIQ)  contract for manufacturing and nonclinical studies support for the development of biologics for neurological-related disorders by the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) of the U.S. Department of Health and Human Services (H...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters